Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
207
-
Total shares
-
29.1M
-
Shares change
-
-834K
-
Total reported value, excl. options
-
$817M
-
Value change
-
-$23.4M
-
Put/Call ratio
-
0.2
-
Number of buys
-
90
-
Number of sells
-
-94
-
Price
-
$28.02
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2022
207 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q4 2022.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 207 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.1M shares
of 50.5M outstanding shares and own 57.71% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.04M shares), FEDERATED HERMES, INC. (3.28M shares), VANGUARD GROUP INC (2.62M shares), DIMENSIONAL FUND ADVISORS LP (1.87M shares), STATE STREET CORP (1.36M shares), PRICE T ROWE ASSOCIATES INC /MD/ (789K shares), GEODE CAPITAL MANAGEMENT, LLC (722K shares), Invesco Ltd. (646K shares), MORGAN STANLEY (603K shares), and FULLER & THALER ASSET MANAGEMENT, INC. (500K shares).
This table shows the top 207 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.